Citations (169)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau & Shelby Sullivan. (2019) Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 131:1, pages 19-30.
Read now
Read now
Nikolaos Sikalias, Theodore Karatzas, Konstantinos Alexiou, Lamprini Mountzalia, Maria Demonakou, Ioannis D. Kostakis, Argyro Zacharioudaki, Apostolos Papalois & Gregory Kouraklis. (2018) Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver. Journal of Investigative Surgery 31:5, pages 366-377.
Read now
Read now
Hassan H A-Kader. (2017) Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD). Expert Review of Gastroenterology & Hepatology 11:10, pages 911-924.
Read now
Read now
Carolin Lackner. (2011) Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective. Expert Review of Gastroenterology & Hepatology 5:2, pages 223-231.
Read now
Read now
Alessandro Federico, Marco Niosi, Camillo Del Vecchio Blanco & Carmela Loguercio. (2008) Emerging drugs for non-alcoholic fatty liver disease. Expert Opinion on Emerging Drugs 13:1, pages 145-158.
Read now
Read now
Vassilios A Sevastianos & Stephanos J Hadziyannis. (2008) Nonalcoholic fatty liver disease: from clinical recognition to treatment. Expert Review of Gastroenterology & Hepatology 2:1, pages 59-79.
Read now
Read now
Sangyeoup Lee, Yun Jin Kim, Tae Yong Jeon, Hyoung Hoi Kim, Sang Woo Oh, Yongsoon Park & Sung Soo Kim. (2006) Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: A cross-sectional case-control study. Scandinavian Journal of Gastroenterology 41:5, pages 566-572.
Read now
Read now
Sanne Dam-Larsen, Maria-Benedicte Franzmann, Per Christoffersen, Klaus Larsen, Ulrik Becker & Flemming Bendtsen. (2005) Histological characteristics and prognosis in patients with fatty liver. Scandinavian Journal of Gastroenterology 40:4, pages 460-467.
Read now
Read now
Articles from other publishers (161)
Kristina-Ana Klaric, Jacqueline Louise Parai, Charis Anthea Kepron, Alfredo Eugene Walker & Christopher Mark Milroy. (2023) Postmortem survey of haemoglobin A1c, non-alcoholic steatohepatitis and liver fibrosis within a general population. Journal of Clinical Pathology 76:9, pages 606-611.
Crossref
Crossref
Tushar Garg, Linda C. Chu, Stefan L. Zimmerman, Clifford R. Weiss, Elliot K. Fishman & Javad R. Azadi. (2023) Prevalence of Hepatic Steatosis in Adults Presenting to the Emergency Department Identified by Unenhanced Chest CT. Current Problems in Diagnostic Radiology 52:1, pages 35-40.
Crossref
Crossref
Angela Saviano, Veronica Ojetti, Christian Zanza, Francesco Franceschi, Yaroslava Longhitano, Ermelinda Martuscelli, Aniello Maiese, Gianpietro Volonnino, Giuseppe Bertozzi, Michela Ferrara & Raffaele La Russa. (2022) Liver Trauma: Management in the Emergency Setting and Medico-Legal Implications. Diagnostics 12:6, pages 1456.
Crossref
Crossref
Ravi Kant & Nisha Batra. 2022. The Principles and Practice of Yoga in Cardiovascular Medicine. The Principles and Practice of Yoga in Cardiovascular Medicine
205
221
.
Xiaoxiao Wang, Huiying Rao, Feng Liu, Lai Wei, Honggui Li & Chaodong Wu. (2021) Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. Cells 10:12, pages 3300.
Crossref
Crossref
Ryan Kolb & Weizhou Zhang. (2020) Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue. Cancers 12:6, pages 1686.
Crossref
Crossref
Luiza de Campos Moreira da Silva, Julia Teixeira de Oliveira, Sandra Tochetto, Claudia Pinto Marques Souza de Oliveira, Rosa Sigrist & Maria Cristina Chammas. (2020) Ultrasound elastography in patients with fatty liver disease. Radiologia Brasileira 53:1, pages 47-55.
Crossref
Crossref
Miao-Juan Shi, Ben-Sheng Dong, Wen-Na Yang, Shi-Bing Su & Hui Zhang. (2019) Preventive and therapeutic role of Tanshinone ⅡA in hepatology. Biomedicine & Pharmacotherapy 112, pages 108676.
Crossref
Crossref
N. Sikalias, Maria Terzopoulou, K. Alexiou, Lamprini Mountzalia, Pagona Kamparoudi, Argyro Zacharioudaki, A. Papalois & T. Karatzas. (2019) The Effect of 30-minute Ischemia on the Levels of IL6, TNFα, NO, Glutathione and Lactic Acid in the Hepatic Tissue of Rats with Hepatic Steatosis. Hellenic Journal of Surgery 91:2, pages 65-74.
Crossref
Crossref
Julie Steen Pedersen & Flemming Bendtsen. 2019. The Human Gut-Liver-Axis in Health and Disease. The Human Gut-Liver-Axis in Health and Disease
23
46
.
Theodore Karatzas, Nikolaos Sikalias, Dimitrios Mantas, Apostolos Papalois, Konstantinos Alexiou, Lamprini Mountzalia & Gregory Kouraklis. (2018) Histopathological changes and onset of severe hepatic steatosis in rats fed a choline‑free diet. Experimental and Therapeutic Medicine.
Crossref
Crossref
Lan N. Tu, Megan R. Showalter, Tomas Cajka, Sili Fan, Viju V. Pillai, Oliver Fiehn & Vimal Selvaraj. (2017) Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Scientific Reports 7:1.
Crossref
Crossref
Sampa Choudhury, Rajesh Singh Laishram & Seter Potom. (2017) HISTOPATHOLOGICAL PATTERNS OF LIVER DISEASES IN MEDICAL AUTOPSIES. Journal of Evidence Based Medicine and Healthcare 4:31, pages 1820-1823.
Crossref
Crossref
Alexandria Atuahene Opata, Khadeen C. Cheesman & Eliza B. Geer. 2017. The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease. The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease
3
26
.
LIANQUN JIA, NAN SONG, GUANLIN YANG, YIXIN MA, XUETAO LI, REN LU, HUIMIN CAO, NI ZHANG, MEILIN ZHU, JUNYAN WANG, XUE LENG, YUAN CAO, YING DU & YUE XU. (2016) Effects of Tanshinone IIA on the modulation of miR-33a and the SREBP-2/Pcsk9 signaling pathway in hyperlipidemic rats. Molecular Medicine Reports 13:6, pages 4627-4635.
Crossref
Crossref
Samuel Klein & Johannes A. Romijn. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1633
1659
.
Qian Wang, Jianjun Du, Pengfei Yu, Bin Bai, Zhanwei Zhao, Shiqi Wang, Junjie Zhu, Quanxin Feng, Yun Gao, Qingchuan Zhao & Chaoxu Liu. (2015) Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis. Scientific Reports 5:1.
Crossref
Crossref
Luke HahnScott B. ReederAlejandro Muñoz del RioPerry J. Pickhardt. (2015) Longitudinal Changes in Liver Fat Content in Asymptomatic Adults: Hepatic Attenuation on Unenhanced CT as an Imaging Biomarker for Steatosis. American Journal of Roentgenology 205:6, pages 1167-1172.
Crossref
Crossref
Yasuhiro Fudaba, Akihiko Oshita, Hirotaka Tashiro & Hideki Ohdan. (2015) Intrahepatic triglyceride measurement and estimation of viability in rat fatty livers by near-infrared spectroscopy. Hepatology Research 45:4, pages 470-479.
Crossref
Crossref
Dimitrios Papandreou. (2015) Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World Journal of Hepatology 7:3, pages 575.
Crossref
Crossref
Wang Nanyue, Yu Youhua, Huang Dawei, Xu Bin, Liu Jia, Li Tongda, Xue Liyuan, Shan Zengyu, Chen Yanping & Wang Jia. (2015) Pulse Diagnosis Signals Analysis of Fatty Liver Disease and Cirrhosis Patients by Using Machine Learning. The Scientific World Journal 2015, pages 1-9.
Crossref
Crossref
Henrik Petrowsky & Ronald W. Busuttil. 2015. Transplantation of the Liver. Transplantation of the Liver
960
974
.
Faidon Magkos, Elisa Fabbrini & Samuel Klein. 2015. Leptin. Leptin
89
101
.
Akira Nii, Tohru Utsunomiya, Mitsuo Shimada, Toru Ikegami, Hiroki Ishibashi, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Hajime Sasaki & Akihiro Kawashima. (2014) A hydrolyzed whey peptide-based diet ameliorates hepatic ischemia–reperfusion injury in the rat nonalcoholic fatty liver. Surgery Today 44:12, pages 2354-2360.
Crossref
Crossref
Perry J. PickhardtLuke HahnAlejandro Muñoz del RioSeong Ho ParkScott B. ReederAdnan Said. (2014) Natural History of Hepatic Steatosis: Observed Outcomes for Subsequent Liver and Cardiovascular Complications. American Journal of Roentgenology 202:4, pages 752-758.
Crossref
Crossref
Xuelian Xiong, Xiaolin Wang, Yan Lu, E. Wang, Zhijian Zhang, Jian Yang, Huijie Zhang & Xiaoying Li. (2014) Hepatic steatosis exacerbated by endoplasmic reticulum stress-mediated downregulation of FXR in aging mice. Journal of Hepatology 60:4, pages 847-854.
Crossref
Crossref
Andreas L. Birkenfeld & Gerald I. Shulman. (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes. Hepatology 59:2, pages 713-723.
Crossref
Crossref
Jun-feng Hou, Xiao-di Zhang, Xiao-guang Wang, Jing Wei & Kai Jiao. 2014. Frontier and Future Development of Information Technology in Medicine and Education. Frontier and Future Development of Information Technology in Medicine and Education
531
543
.
Elisa Fabbrini & Faidon Magkos. 2014. Treatment of the Obese Patient. Treatment of the Obese Patient
121
135
.
Elisa Fabbrini & Faidon Magkos. 2014. Treatment of the Obese Patient. Treatment of the Obese Patient
121
135
.
Stephen BravoJoshua LowndesStephanie SinnettZhiping YuJames Rippe. (2013) Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles. Applied Physiology, Nutrition, and Metabolism 38:6, pages 681-688.
Crossref
Crossref
Sanjaya Kumar Satapathy, Satheesh Nair & Jason M. Vanatta. (2013) Nonalcoholic fatty liver disease following liver transplantation. Hepatology International 7:2, pages 400-412.
Crossref
Crossref
Vasundhara Devi D, Madhu Latha M, Sumapreethi A, Sharma S.S.B & Priyanka M. (2013) A STUDY OF NON ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME. Journal of Evolution of medical and Dental Sciences 2:4, pages 375-382.
Crossref
Crossref
Michael J. J. Chu, Anthony J. R. Hickey, Anthony R. J. Phillips & Adam S. J. R. Bartlett. (2013) The Impact of Hepatic Steatosis on Hepatic Ischemia-Reperfusion Injury in Experimental Studies: A Systematic Review. BioMed Research International 2013, pages 1-12.
Crossref
Crossref
M. Hisada, Y. Ota, X. Zhang, A.M. Cameron, B. Gao, R.A. Montgomery, G.M. Williams & Z. Sun. (2012) Successful Transplantation of Reduced-Sized Rat Alcoholic Fatty Livers Made Possible by Mobilization of Host Stem Cells. American Journal of Transplantation 12:12, pages 3246-3256.
Crossref
Crossref
Yukiyasu Okamura, Hiroyuki Sugimoto, Suguru Yamada, Tsutomu Fujii, Shuji Nomoto, Shin Takeda, Yasuhiro Kodera & Akimasa Nakao. (2012) Risk Factors for Hepatic Steatosis After Pancreatectomy. Pancreas 41:7, pages 1067-1072.
Crossref
Crossref
Perry J. Pickhardt, Seong Ho Park, Luke Hahn, Sung-Gyu Lee, Kyongtae T. Bae & Eun Sil Yu. (2011) Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. European Radiology 22:5, pages 1075-1082.
Crossref
Crossref
Maud Lemoine & Lawrence Serfaty. (2012) Stéatopathies métaboliques. La Presse Médicale 41:2, pages 169-189.
Crossref
Crossref
Yukihiro Sanada, Taizen Urahashi, Taiichi Wakiya, Noriki Okada, Shuji Hishikawa, Youichi Kawano, Kentaro Ushijima, Shinya Otomo, Koichi Sakamoto & Koichi Mizuta. (2011) Non-alcoholic steatohepatitis caused by malnutrition after pediatric liver transplantation. Pediatrics International 53:6, pages 1077-1081.
Crossref
Crossref
W. Nseir, A. Shalata, A. Marmor & N. Assy. (2011) Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease. Digestive Diseases and Sciences 56:12, pages 3439-3449.
Crossref
Crossref
Krzysztof Lukasz Kopec & David Burns. (2011) Nonalcoholic Fatty Liver Disease. Nutrition in Clinical Practice 26:5, pages 565-576.
Crossref
Crossref
Shirou Tanoue, Hirofumi Uto, Ryo Kumamoto, Shiho Arima, Shinichi Hashimoto, Yuichiro Nasu, Yoichiro Takami, Akihiro Moriuchi, Toshio Sakiyama, Makoto Oketani, Akio Ido & Hirohito Tsubouchi. (2011) Liver regeneration after partial hepatectomy in rat is more impaired in a steatotic liver induced by dietary fructose compared to dietary fat. Biochemical and Biophysical Research Communications 407:1, pages 163-168.
Crossref
Crossref
Silvia Colombo, Livio Belloli, Maurizio Zaccanelli, Elisabetta Badia, Carlo Jamoletti, Marco Buonocore & Paolo Del Poggio. (2011) Normal liver stiffness and its determinants in healthy blood donors. Digestive and Liver Disease 43:3, pages 231-236.
Crossref
Crossref
Peter J. Kneuertz, Shishir K. Maithel, Charles A. Staley & David A. Kooby. (2010) Chemotherapy-Associated Liver Injury: Impact on Surgical Management of Colorectal Cancer Liver Metastases. Annals of Surgical Oncology 18:1, pages 181-190.
Crossref
Crossref
Michael R. Charlton. (2011) Fibrosing NASH: On Being a Blind Man in a Dark Room Looking for a Black Cat (That Isn't There). Gastroenterology 140:1, pages 25-28.
Crossref
Crossref
M. Lemoine & L. Serfaty. (2011) Foie métabolique. EMC - Hépatologie 6:4, pages 1-12.
Crossref
Crossref
Samuel Klein, Elisa Fabbrini & Johannes A. Romijn. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1605
1632
.
Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon, Roberto José de Carvalho-Filho, Débora Yumi Hayashida, Jenny Hue Jiuan Wang, Tatiana Santana Souza, Christini Takemi Emori, Maria Lucia Gomes Ferraz & Antonio Eduardo Benedito Silva. (2010) Clinical characteristics associated with hepatic steatosis on ultrasonography in patients with elevated alanine aminotransferase. Sao Paulo Medical Journal 128:6, pages 342-347.
Crossref
Crossref
Vlad Ratziu, Stefano Bellentani, Helena Cortez-Pinto, Chris Day & Giulio Marchesini. (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. Journal of Hepatology 53:2, pages 372-384.
Crossref
Crossref
J. Bernadette Moore. (2010) Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. Proceedings of the Nutrition Society 69:2, pages 211-220.
Crossref
Crossref
Brad Q. Starley, Christopher J. Calcagno & Stephen A. Harrison. (2010) Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection. Hepatology 51:5, pages 1820-1832.
Crossref
Crossref
Amit D. Tevar, Calissia Clarke, Jiang Wang, Steven M. Rudich, Steve E. Woodle, Alex B. Lentsch & Michael L. Edwards. (2010) Clinical Review of Nonalcoholic Steatohepatitis in Liver Surgery and Transplantation. Journal of the American College of Surgeons 210:4, pages 515-526.
Crossref
Crossref
Cody J. BoycePerry J. PickhardtDavid H. KimAndrew J. TaylorThomas C. WinterRichard J. BruceMary J. LindstromJ. Louis Hinshaw. (2010) Hepatic Steatosis (Fatty Liver Disease) in Asymptomatic Adults Identified by Unenhanced Low-Dose CT. American Journal of Roentgenology 194:3, pages 623-628.
Crossref
Crossref
Emel Ahishali, Kadir Demir, Bulent Ahishali, Filiz Akyuz, Binnur Pinarbasi, Sule Poturoglu, Duygu Ibrisim, Mine Gulluoglu, Sadakat Ozdil, Fatih Besisik, Sabahattin Kaymakoglu, Gungor Boztas, Yilmaz Cakaloglu, Zeynel Mungan, Yurdagul Canberk & Atilla Okten. (2010) Electron microscopic findings in non-alcoholic fatty liver disease: Is there a difference between hepatosteatosis and steatohepatitis?. Journal of Gastroenterology and Hepatology 25:3, pages 619-626.
Crossref
Crossref
Elisa Fabbrini, Shelby Sullivan & Samuel Klein. (2010) Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 51:2, pages 679-689.
Crossref
Crossref
Yoshiaki YAJIMA, Takako SUGITA, Taketoshi SATO, Takeru MITA, Mayumi TOZUKA & Isao KUROSAWA. (2010) Ultrasound findings of fatty liver using advanced ultrasonoscope equipped with differential tissue harmonic imaging: re-evaluation of diagnostic criteria in comparison with CT findings. Choonpa Igaku 37:5, pages 587-592.
Crossref
Crossref
Kouichi Miura, Ekihiro Seki, Hirohide Ohnishi & David A. Brenner. (2010) Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2010, pages 1-9.
Crossref
Crossref
H. Hesham A-Kader. (2009) Nonalcoholic fatty liver disease in children living in the obeseogenic society. World Journal of Pediatrics 5:4, pages 245-254.
Crossref
Crossref
M. Lemoine. (2009) Stéatopathie métabolique: définition et histoire naturelle. Gastroentérologie Clinique et Biologique 33:5, pages 398-404.
Crossref
Crossref
Huda M. Noujaim, Jean de Ville de Goyet, Edna F.S. Montero, Cristiane M.F. Ribeiro, Vera L. Capellozzi, Fabio Crescentini, Matheo Casagrande, Regina G. Santos, Lillian Curvello, Marcelo P. de Miranda & Tercio Genzini. (2009) Expanding Postmortem Donor Pool Using Steatotic Liver Grafts: A New Look. Transplantation 87:6, pages 919-925.
Crossref
Crossref
Nuh N. Rahbari, Moritz Koch, Arianeb Mehrabi, Kathrin Weidmann, Edith Motschall, Christoph Kahlert, Markus W. Büchler & Jürgen Weitz. (2008) Portal Triad Clamping Versus Vascular Exclusion for Vascular Control During Hepatic Resection: A Systematic Review and Meta-analysis. Journal of Gastrointestinal Surgery 13:3, pages 558-568.
Crossref
Crossref
Nila Rafiq, Chunhong Bai, Yun Fang, Manirath Srishord, Arthur McCullough, Terry Gramlich & Zobair M. Younossi. (2009) Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver. Clinical Gastroenterology and Hepatology 7:2, pages 234-238.
Crossref
Crossref
Carrie A. Millward, Lindsay C. Burrage, Haifeng Shao, David S. Sinasac, Jean H. Kawasoe, Annie E. Hill-Baskin, Sheila R. Ernest, Aga Gornicka, Chang-Wen Hsieh, Sorana Pisano, Joseph H. Nadeau & Colleen M. Croniger. (2009) Genetic factors for resistance to diet-induced obesity and associated metabolic traits on mouse chromosome 17. Mammalian Genome 20:2, pages 71-82.
Crossref
Crossref
Stefano Bellentani & Mariano Marino. (2009) Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Annals of Hepatology 8, pages S4-S8.
Crossref
Crossref
ELIZABETH M. BRUNT & DINA G. TINIAKOS. 2009. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas
1087
1114
.
Eugen Florin Georgescu. (2008) Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?. Advances in Therapy 25:11, pages 1141-1174.
Crossref
Crossref
Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Steven Woon-Choi Tsang, Alex Yui Hui, Anthony Wing-Hong Chan, Paul Cheung-Lung Choi, Wing-Yee So, Ada Mei-Ling Tse, Francis Ka-Leung Chan, Joseph Jao-Yiu Sung & Henry Lik-Yuen Chan. (2008) Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. Journal of Gastroenterology and Hepatology 23:6, pages 914-921.
Crossref
Crossref
Clifford S. Cho, Sean Curran, Lawrence H. Schwartz, David A. Kooby, David S. Klimstra, Jinru Shia, Alejandro Munoz, Yuman Fong, William R. Jarnagin, Ronald P. DeMatteo, Leslie H. Blumgart & Michael I. D'Angelica. (2008) Preoperative Radiographic Assessment of Hepatic Steatosis with Histologic Correlation. Journal of the American College of Surgeons 206:3, pages 480-488.
Crossref
Crossref
P. Loria, A. Lonardo, S. Bellentani, C.P. Day, G. Marchesini & N. Carulli. (2007) Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question. Nutrition, Metabolism and Cardiovascular Diseases 17:9, pages 684-698.
Crossref
Crossref
Tara M. Wallace, Kristina M. Utzschneider, Jenny Tong, Darcy B. Carr, Sakeneh Zraika, Daniel D. Bankson, Robert H. Knopp & Steven E. Kahn. (2007) Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat. Diabetes Care 30:10, pages 2673-2678.
Crossref
Crossref
Vladimir Savransky, Shannon Bevans, Ashika Nanayakkara, Jianguo Li, Philip L. Smith, Michael S. Torbenson & Vsevolod Y. Polotsky. (2007) Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 293:4, pages G871-G877.
Crossref
Crossref
Reeta Veteläinen, Arlène van Vliet & Thomas M van Gulik. (2007) Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. Journal of Gastroenterology and Hepatology 22:9, pages 1526-1533.
Crossref
Crossref
Clare Nugent & Zobair M Younossi. (2007) Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nature Clinical Practice Gastroenterology & Hepatology 4:8, pages 432-441.
Crossref
Crossref
R Veteläinen, R J Bennink, A K van Vliet & T M van Gulik. (2007) Mild steatosis impairs functional recovery after liver resection in an experimental model. British Journal of Surgery 94:8, pages 1002-1008.
Crossref
Crossref
Arthur Zimmermann. 2007. Textbook of Hepatology. Textbook of Hepatology
489
499
.
Geoffrey C. Farrell. 2007. Textbook of Hepatology. Textbook of Hepatology
1193
1208
.
Suk Seo, Kalyani Maganti, Manjit Khehra, Rajendra Ramsamooj, Alexander Tsodikov, Christopher Bowlus, John McVicar, Mark Zern & Natalie Torok. (2007) De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transplantation 13:6, pages 844-847.
Crossref
Crossref
Yoshihisa KodamaChaan S. NgTsung T. WuGregory D. AyersSteven A. CurleyEddie K. AbdallaJean Nicolas VautheyChusilp Charnsangavej. (2007) Comparison of CT Methods for Determining the Fat Content of the Liver. American Journal of Roentgenology 188:5, pages 1307-1312.
Crossref
Crossref
Sherif Saadeh. (2017) Nonalcoholic Fatty Liver Disease and Obesity. Nutrition in Clinical Practice 22:1, pages 1-10.
Crossref
Crossref
Koji Yamamoto, Yasutsugu Takada, Yasuhiro Fujimoto, Hironori Haga, Fumitaka Oike, Nobuaki Kobayashi & Koichi Tanaka. (2007) Nonalcoholic Steatohepatitis in Donors for Living Donor Liver Transplantation. Transplantation 83:3, pages 257-262.
Crossref
Crossref
Janus P. Ong & Zobair M. Younossi. (2007) Epidemiology and Natural History of NAFLD and NASH. Clinics in Liver Disease 11:1, pages 1-16.
Crossref
Crossref
David Tendler, Sauyu Lin, William S. YancyJr.Jr., John Mavropoulos, Pam Sylvestre, Don C. Rockey & Eric C. Westman. (2007) The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study. Digestive Diseases and Sciences 52:2, pages 589-593.
Crossref
Crossref
Reeta Vetel??inen, Arl??ne K. van Vliet & Thomas M. van Gulik. (2007) Severe Steatosis Increases Hepatocellular Injury and Impairs Liver Regeneration in a Rat Model of Partial Hepatectomy. Annals of Surgery 245:1, pages 44-50.
Crossref
Crossref
Martijn C. G. J. Brouwers, Monique A. L. Bilderbeek-Beckers, Anna M. Georgieva, Carla J. H. van der Kallen, Marleen M. J. van Greevenbroek & Tjerk W. A. de Bruin. (2006) Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids. Clinical Science 112:2, pages 123-130.
Crossref
Crossref
Koichiro Hata, Rene Hany Tolba, Lai Wei, Benedict Marie Doorschodt, Reinhard Büttner, Yuzo Yamamoto & Thomas Minor. (2007) Impact of polysol, a newly developed preservation solution, on cold storage of steatotic rat livers. Liver Transplantation 13:1, pages 114-121.
Crossref
Crossref
Kristina M. Utzschneider & Steven E. Kahn. (2006) The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism 91:12, pages 4753-4761.
Crossref
Crossref
J.A. Perez-Daga, J. Santoyo, M.A. Suárez, J.A. Fernández-Aguilar, C. Ramírez, A. Rodríguez-Cañete, J.M. Aranda, B. Sánchez-Pérez, C. Montiel, D. Palomo, M. Ruiz & A. Mate. (2006) Influence of Degree of Hepatic Steatosis on Graft Function and Postoperative Complications of Liver Transplantation. Transplantation Proceedings 38:8, pages 2468-2470.
Crossref
Crossref
Reeta L. Veteläinen, Roelof J. Bennink, Kora de Bruin, Arlène van Vliet & Thomas M. van Gulik. (2006) Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of severity of steatosis in a rat model. European Journal of Nuclear Medicine and Molecular Imaging 33:10, pages 1107-1114.
Crossref
Crossref
Shira Zelber-Sagi, Dorit Nitzan-Kaluski, Zamir Halpern & Ran Oren. (2006) Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver International 26:7, pages 856-863.
Crossref
Crossref
Isabelle Leclercq & Christine Sempoux. (2006) Hépatopathie non alcoolique: de la stéatose à la cirrhoseNonalcoholic fatty liver disease: from steatosis to cirrhosis. Acta Endoscopica 36:3, pages 299-314.
Crossref
Crossref
D. Moreno-Sánchez. (2006) Epidemiología e historia natural de la hepatopatía grasa no alcohólica primaria. Gastroenterología y Hepatología 29:4, pages 244-254.
Crossref
Crossref
Nazia Selzner, Markus Selzner, Wolfram Jochum, Beatrice Amann-Vesti, Rolf Graf & Pierre-Alain Clavien. (2006) Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. Journal of Hepatology 44:4, pages 694-701.
Crossref
Crossref
DAISUKE MORIOKA, KAZUTERU WATANABE, HIROCHIKA MAKINO, SHUJI SAITO, MICHIO UEDA, TORU KUBOTA, HITOSHI SEKIDO, KEN-ICHI MATSUO, YASUSHI ICHIKAWA, ITARU ENDO, SHINJI TOGO & HIROSHI SHIMADA. (2006) Safety limit of the extent of hepatectomy for rats with moderately fatty liver: Experimental study concerning living liver donor safety. Journal of Gastroenterology and Hepatology 21:2, pages 367-373.
Crossref
Crossref
Geoffrey C. Farrell & Claire Z. Larter. (2006) Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis. Hepatology 43:Supplement 1, pages S99-S112.
Crossref
Crossref
Brent A. Neuschwander-Tetri. 2006. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
1031
1063
.
H. REYNAERT, A. GEERTS & J. HENRION. (2005) Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones. Alimentary Pharmacology and Therapeutics 22:10, pages 897-905.
Crossref
Crossref
Janus P. Ong & Zobair M. Younossi. (2005) Approach to the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 9:4, pages 617-634.
Crossref
Crossref
Mariana Machado & Helena Cortez-Pinto. (2005) Non-alcoholic fatty liver disease and insulin resistance. European Journal of Gastroenterology & Hepatology 17:8, pages 823-826.
Crossref
Crossref
Akira Kitase, Keisuke Hino, Takakazu Furutani, Michiari Okuda, Toshikazu Gondo, Isao Hidaka, Yuichi Hara, Yuhki Yamaguchi & Kiwamu Okita. (2005) In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis. Journal of Gastroenterology 40:6, pages 617-624.
Crossref
Crossref
Se Hyung Kim, Jeong Min Lee, Jong Hyo Kim, Kwang Gi Kim, Joon Koo Han, Kyoung Ho Lee, Seong Ho Park, Nam-Joon Yi, Kyung-Suk Suh, Su Kyung An, Young Jun Kim, Kyu Ri Son, Hye Seung Lee & Byung Ihn Choi. (2005) Appropriateness of a Donor Liver with Respect to Macrosteatosis: Application of Artificial Neural Networks to US Images—Initial Experience. Radiology 234:3, pages 793-803.
Crossref
Crossref
Rahul S. KOTIWenxuan YANGGeorgios GLANTZOUNISAlberto QUAGLIABrian R. DAVIDSONAlexander M. SEIFALIAN. (2004) Effect of ischaemic preconditioning on hepatic oxygenation, microcirculation and function in a rat model of moderate hepatic steatosis. Clinical Science 108:1, pages 55-63.
Crossref
Crossref
U Becker. 2005. Comprehensive Handbook of Alcohol Related Pathology. Comprehensive Handbook of Alcohol Related Pathology
467
480
.
NICHOLAS N. NISSEN & STEVEN D. COLQUHOUN. 2005. Transplantation of the Liver. Transplantation of the Liver
915
928
.
Ayako Suzuki, Paul Angulo, James Lymp, Jennifer St. Sauver, Ayako Muto, Toshihide Okada & Keith Lindor. (2005) Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 41:1, pages 64-71.
Crossref
Crossref
Nadya Kagansky, Shmuel Levy, Daniel Keter, Ephraim Rimon, Zhomicky Taiba, Zvi Fridman, David Berger, Hilla Knobler & Stephen Malnick. (2004) Non-alcoholic fatty liver disease - a common and benign finding in octogenarian patients. Liver International 24:6, pages 588-594.
Crossref
Crossref
Helena Cortez-Pinto & Maria Ermelinda Camilo. (2004) Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Practice & Research Clinical Gastroenterology 18:6, pages 1089-1104.
Crossref
Crossref
Jeffrey D. Browning, Lidia S. Szczepaniak, Robert Dobbins, Pamela Nuremberg, Jay D. Horton, Jonathan C. Cohen, Scott M. Grundy & Helen H. Hobbs. (2004) Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40:6, pages 1387-1395.
Crossref
Crossref
Stefano Bellentani, Giorgio Bedogni, Lucia Miglioli & Claudio Tiribelli. (2004) The epidemiology of fatty liver. European Journal of Gastroenterology & Hepatology 16:11, pages 1087-1093.
Crossref
Crossref
Arthur J. Mccullough. 2004. Fatty Liver Disease. Fatty Liver Disease
23
37
.
Anne Burke & Michael R. Lucey. 2004. Fatty Liver Disease. Fatty Liver Disease
208
217
.
Udayan M. Apte, Rachel Mcree & Shashi K. Ramaiah. (2016) Hepatocyte Proliferation is the Possible Mechanism for the Transient Decrease in Liver Injury During Steatosis Stage of Alcoholic Liver Disease. Toxicologic Pathology 32:5, pages 567-576.
Crossref
Crossref
Constance E. Ruhl & James E. Everhart. (2004) Epidemiology of nonalcoholic fatty liver. Clinics in Liver Disease 8:3, pages 501-519.
Crossref
Crossref
Michael W. Bradbury & Paul D. Berk. (2004) Lipid metabolism in hepatic steatosis. Clinics in Liver Disease 8:3, pages 639-671.
Crossref
Crossref
Jeffrey D. Browning & Jay D. Horton. (2004) Molecular mediators of hepatic steatosis and liver injury. Journal of Clinical Investigation 114:2, pages 147-152.
Crossref
Crossref
Christopher D. Anderson, Steve Meranze, Peter BreamJr.Jr., D. Lee Gorden, J. Kelly Wright, C. Wright Pinson & Ravi S. Chari. (2022) Contralateral Portal Vein Embolization for Hepatectomy in the Setting of Hepatic Steatosis. The American Surgeon 70:7, pages 609-612.
Crossref
Crossref
Lafaine M. Grant & Mauricio Lisker-Melman. (2004) Nonalcoholic fatty liver disease. Annals of Hepatology 3:3, pages 93-99.
Crossref
Crossref
Anne Burke & Michael R. Lucey. (2004) Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis and Orthotopic Liver Transplantation. American Journal of Transplantation 4:5, pages 686-693.
Crossref
Crossref
Jeffrey D Browning, K Shiva Kumar, M Hossein Saboorian & Dwain L Thiele. (2004) Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis. American Journal of Gastroenterology 99:2, pages 292-298.
Crossref
Crossref
Suthat Liangpunsakul & Naga Chalasani. (2003) Treatment of nonalcoholic fatty liver disease. Current Treatment Options in Gastroenterology 6:6, pages 455-463.
Crossref
Crossref
S.D.H. Malnick, M. Beergabel & H. Knobler. (2003) Non-alcoholic fatty liver: a common manifestation of a metabolic disorder. QJM 96:10, pages 699-709.
Crossref
Crossref
Perry Hookman & Jamie S. Barkin. (2003) Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach:. Lin HZ, Yang SQ, Chuckaree C, et al. Metformin reverses fatty liver disease in obese, Leptin-deficient Micenat Med 2000;6:998-1003. The American Journal of Gastroenterology 98:9, pages 2093-2097.
Crossref
Crossref
Yuji Soejima, Mitsuo Shimada, Taketoshi Suehiro, Keiji Kishikawa, Tomoharu Yoshizumi, Koji Hashimoto, Ryosuke Minagawa, Shoji Hiroshige, Takahiro Terashi, Mizuki Ninomiya, Satoko Shiotani, Noboru Harada & Keizo Sugimachi. (2003) Use of steatotic graft in living-donor liver transplantation. Transplantation 76:2, pages 344-348.
Crossref
Crossref
Nazia Selzner, Markus Selzner, Wolfram Jochum & Pierre-Alain Clavien. (2003) Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. Journal of Hepatology 39:1, pages 55-61.
Crossref
Crossref
Markus Selzner, Rolf Graf & Pierre-Alain Clavien. (2003) IL-6: a magic potion for liver transplantation?. Gastroenterology 125:1, pages 256-259.
Crossref
Crossref
Diamond Joy, Vallipuram R. Thava & Brian B. Scott. (2003) Diagnosis of fatty liver disease. European Journal of Gastroenterology & Hepatology 15:5, pages 539-543.
Crossref
Crossref
Diamond Joy, Vallipuram R Thava & Brian B Scott. (2003) Diagnosis of fatty liver disease. European Journal of Gastroenterology & Hepatology 15:5, pages 539-543.
Crossref
Crossref
B Neuschwander-Tetri. (2003) Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 37:5, pages 1202-1219.
Crossref
Crossref
G Marchesini. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:4, pages 917-923.
Crossref
Crossref
Perry Hookman & Jamie S. Barkin. (2003) Current biochemical studies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) suggest a new therapeutic approach. Lin Hz, Yang SQ, Chuckaree C, et al., Metformin's Reverses Fatty Liver Disease in Obese Leptin-Deficient Mice, Nature Medicine 2000;6(8):998-1003. The American Journal of Gastroenterology 98:2, pages 495-499.
Crossref
Crossref
Henryk DancygierH. Dancygier. 2003. Klinische Hepatologie. Klinische Hepatologie
659
671
.
C Ryan. (2002) One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transplantation 8:12, pages 1114-1122.
Crossref
Crossref
Wael I Youssef & Arthur J McCullough. (2002) Steatohepatitis in obese individuals. Best Practice & Research Clinical Gastroenterology 16:5, pages 733-747.
Crossref
Crossref
Farin Amersi, Douglas G. Farmer, Gray D. Shaw, Hirohisa Kato, Ana J. Coito, Fady Kaldas, Delai Zhao, Charles R. Lassman, Judy Melinek, Jeffrey Ma, Hans-Dieter Volk, Jerzy W. Kupiec-Weglinski, Jeffrey Ma & Ronald W. Busuttil. (2002) P‐Selectin Glycoprotein Ligand‐1 (rPSGL‐Ig)‐Mediated Blockade of CD62 Selectin Molecules Protects Rat Steatotic Liver Grafts from Ischemia/Reperfusion Injury. American Journal of Transplantation 2:7, pages 600-608.
Crossref
Crossref
I. TAVARES DE ALMEIDA, H. CORTEZ-PINTO, G. FIDALGO, D. RODRIGUES & M.E. CAMILO. (2002) Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clinical Nutrition 21:3, pages 219-223.
Crossref
Crossref
C Imber. (2002) Hepatic steatosis and its relationship to transplantation. Liver Transplantation 8:5, pages 415-423.
Crossref
Crossref
Arthur J. McCullough. (2002) Update on Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 34:3, pages 255-262.
Crossref
Crossref
Baburao Koneru & George Dikdan. (2002) HEPATIC STEATOSIS AND LIVER TRANSPLANTATION CURRENT CLINICAL AND EXPERIMENTAL PERSPECTIVES. Transplantation 73:3, pages 325-330.
Crossref
Crossref
Yu Fan Cheng, Chao Long Chen, Chia-Yun Lai, Tai Yi Chen, Tung Liang Huang, Tze Yu Lee, Chen Lung Lin, Roger Lord, Yaw Chen, Hock Liew Eng, Tair-Long Pan, Tzong-Hsien Lee, Yu-Hsueh Wang, Yukio Iwashita, Seigo Kitano & Shigeru Goto. (2001) ASSESSMENT OF DONOR FATTY LIVERS FOR LIVER TRANSPLANTATION1. Transplantation 71:9, pages 1221-1225.
Crossref
Crossref
Markus Selzner, Hannes A. RüDiger, David Sindram, John Madden & Pierre-Alain Clavien. (2000) Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 32:6, pages 1280-1288.
Crossref
Crossref
Per Björkman, Gunnar Sundström, Béla Veress & Anders Widell. (2003) Assessment of Liver Disease and Biochemical and Immunological Markers in Swedish Blood Donors with Isolated GB Virus C/Hepatitis G Virus Viremia. Vox Sanguinis 78:3, pages 143-148.
Crossref
Crossref
Markus Selzner & Pierre-Alain Clavien. (2000) Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 31:1, pages 35-42.
Crossref
Crossref
H. Cortez-Pinto, M.E. Camilo, A. Baptista, A.G. De Oliveira & M.C. De Moura. (1999) Non-alcoholic fatty liver: another feature of the metabolicsyndrome?. Clinical Nutrition 18:6, pages 353-358.
Crossref
Crossref
PETER Schemmer, ROBERT Schoonhoven, JAMES A. Swenberg, HARTWIG Bunzendahl, JAMES A. Raleigh, JOHN J. Lemasters & RONALD G. Thurman. (1999) Gentle organ manipulation during harvest as a key determinant of survival of fatty livers after transplantation in the rat. Transplant International 12:5, pages 351-359.
Crossref
Crossref
Kazuhiko Yamagami, Yuzo Yamamoto, Makoto Kume, Syuji Kimoto, Hidekazu Yamamoto, Nobuhiro Ozaki, Masayuki Yamamoto, Yasuyuki Shimahara, Shinya Toyokuni & Yoshio Yamaoka. (1998) Heat Shock Preconditioning Ameliorates Liver Injury Following Normothermic Ischemia–Reperfusion in Steatotic Rat Livers. Journal of Surgical Research 79:1, pages 47-53.
Crossref
Crossref
Willem A. Marsman, Russell H. Wiesner, Luis Rodriguez, Kenneth P. Batts, Michael K. Porayko, J. Eileen Hay, Gregory J. Gores & Ruud A. F. Krom. (1996) USE OF FATTY DONOR LIVER IS ASSOCIATED WITH DIMINISHED EARLY PATIENT AND GRAFT SURVIVAL. Transplantation 62:9, pages 1246-1251.
Crossref
Crossref
Toshiyuki Kitai, Bertrand Beauvoit & Britton Chance. (1996) OPTICAL DETERMINATION OF FATTY CHANGE OF THE GRAFT LIVER WITH NEAR-INFRARED TIME-RESOLVED SPECTROSCOPY. Transplantation 62:5, pages 642-647.
Crossref
Crossref
Mayani C. Reddy, Baburao Koneru, Sunil Soni & Deepan Patel. (1996) 31P NUCLEAR MAGNETIC RESONANCE STUDY OF PHOSPHOLIPIDS IN ISCHEMIA/REPERFUSION INJURY IN A RAT FATTY LIVER MODEL. Transplantation 61:8, pages 1151-1155.
Crossref
Crossref
Franco Trevisani, Alessandra Colantoni, Paolo Caraceni & David H. Van Thiel. (1996) The use of donor fatty liver for liver transplantation: a challenge or a quagmire?. Journal of Hepatology 24:1, pages 114-121.
Crossref
Crossref
M. J. BOFFA, R.J.G. CHALMERS, N.Y. HABOUBI, M. SHOMAF & D.M. MITCHELL. (2006) Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal. British Journal of Dermatology 133:5, pages 774-778.
Crossref
Crossref
John J. Lemasters, Hartwig Bunzendahl & Ronald G. Thurman. (1995) Reperfusion injury to donor livers stored for transplantation. Liver Transplantation and Surgery 1:2, pages 124-138.
Crossref
Crossref
Ai-Min Hui, Seiji Kawasaki, Masatoshi Makuuchi, Jun Nakayama, Toshihiko Ikegami & Shinichi Miyagawa. (1994) Liver injury following normothermic ischemia in steatotic rat liver. Hepatology 20:5, pages 1287-1293.
Crossref
Crossref
Kenneth Jensen & Christian Gluud. (1994) The mallory body: Morphological, clinical and experimental studies (part 1 of a literature survey). Hepatology 20:4, pages 1061-1077.
Crossref
Crossref
V. T. Savolainen, K. Liesto, A. Männikkö, A. Penttilä & P. J. Karhunen. (2007) Alcohol Consumption and Alcoholic Liver Disease: Evidence of a Threshold Level of Effects of Ethanol. Alcoholism: Clinical and Experimental Research 17:5, pages 1112-1117.
Crossref
Crossref
Mats Öström & Anders Eriksson. (1993) Single-vehicle crashes and alcohol: a retrospective study of passenger car fatalities in Northern Sweden. Accident Analysis & Prevention 25:2, pages 171-176.
Crossref
Crossref
D. G. D. WightD. G. D. Wight. 1993. Atlas of Liver Pathology. Atlas of Liver Pathology
9
13
.
T Andersen. (1992) Liver and gallbladder disease before and after very-low-calorie diets. The American Journal of Clinical Nutrition 56:1, pages 235S-239S.
Crossref
Crossref
James H. Grendell, John P. Cello, William Margaretten & David C. Heilbron. (1983) Impact of preshunt liver histology on survival following portasystemic shunt surgery for bleeding esophageal varices. Digestive Diseases and Sciences 28:1, pages 44-55.
Crossref
Crossref
Peter Kryger, Per Christoffersen & The Copenhagen Hepatitis Acuta Programme. (2008) Light microscopic morphology of acute hepatitis non‐A, non‐B. A comparison with hepatitis type A and B. Liver 2:3, pages 200-206.
Crossref
Crossref
Birgitte Kringsholm & Per Christoffersen. (1982) Liver pathology in fatal drug addiction. Forensic Science International 20:2, pages 141-151.
Crossref
Crossref
PER HORNBØLL & TOM SKYHØJ OLSEN. (2009) FATTY CHANGES IN THE LIVER. Acta Pathologica Microbiologica Scandinavica Series A :Pathology 90A:1-6, pages 199-205.
Crossref
Crossref
Gianfranco Bianucci, Stefania Pinto, Susanna Maddali Bongi & Silvana Saullo. (1981) Critical evaluation of γ-glutamyl transpeptidase levels in rheumatoid arthritis and laboratory indices of disease activity. La Ricerca in Clinica e in Laboratorio 11:2, pages 159-168.
Crossref
Crossref